Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN106866389A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106866389A reveals copper-catalyzed asymmetric synthesis. Offers high enantioselectivity up to 95% ee for pharmaceutical intermediates.